Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Esketamine for Acute Suicidal Crisis
NCT07888933Phase 2Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2027
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 2 trial of esketamine in suicidal ideation, Suicidal Behavior (SB), sponsored by Universidade de São Paulo. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
suicidal ideationSuicidal Behavior (SB)
Beyond the preview
Go deeper on NCT07888933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888933.